OmniAb (OABI) Receivables (2021 - 2026)
OmniAb (OABI) reported Receivables of $16.1 million for Q1 2026, up 124.84% year-over-year from $7.2 million in Q1 2025, and up 97.06% on a QoQ basis from $8.2 million in Q4 2025.
OmniAb (OABI) has 6 years of Receivables data on file, last reported at $16.1 million in Q1 2026.
- Quarterly Receivables rose 124.84% year-over-year to $16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.1 million (up 124.84% YoY) and the FY2025 annual result came in at $8.2 million, up 4.04% from the prior year.
- Receivables climbed to $16.1 million in Q1 2026 per OABI's latest filing, from $8.2 million in the prior quarter.
- Across five years, Receivables topped out at $30.3 million in Q4 2022 and bottomed at $1.8 million in Q1 2023.
- The 5-year median for Receivables is $6.5 million (2023), against an average of $8.0 million.
- The widest annual swing landed in 2023, when Receivables tumbled 84.67%; it then soared 124.84% in 2026.
- Tracing OABI's Receivables over 5 years: stood at $30.3 million in 2022, then plunged by 84.67% to $4.6 million in 2023, then jumped by 69.51% to $7.9 million in 2024, then gained by 4.04% to $8.2 million in 2025, then soared by 97.06% to $16.1 million in 2026.
- Per Business Quant, the three latest OABI Receivables figures stand at $16.1 million (Q1 2026), $8.2 million (Q4 2025), and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 16.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.14 Mn |
| Dec 31, 2025 | 8.19 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 3.11 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 7.87 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 4.64 Mn |
| Sep 30, 2023 | 6.14 Mn |
| Jun 30, 2023 | 8.61 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 30.29 Mn |
| Dec 31, 2021 | 21.14 Mn |